Deals, Financing

PDL pours in $70 million in debt financing to Durata Therapeutics

Posted on 07 November 2013

Tags: , , ,

PDL will provide Durata with up to $70 million of debt financing with a five year term.

PDL BioPharma announced that it closed a debt financing transaction with Durata Therapeutics.

It will receive interest on the principal amount outstanding and a security interest in substantially all of Durata's assets.

Durata's lead product candidate, dalbavancin, is an intravenous antibiotic product candidate for the treatment of patients with acute bacterial skin and skin structure infections.

The total financing of up to $70 million was provided pursuant to a credit agreement that included an initial $25 million in cash funded to Durata on October 31, 2013.

Provides up to $45 million in additional funds to Durata.

With $15 million of funding upon U.S. regulatory approval of dalbavancin.

The remaining $30 million funded within nine months after regulatory approval of dalbavancin, at Durata's election.

For further deal information visit Current Agreements (subscription required)



Read: more on financing deals in pharma, biotech, life science partnering deal news, insights and glossary

View: Current Partnering’s Financing Scorecard – view top life science financing deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter


Print Friendly, PDF & Email

Leave a Reply